We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




New Automated Chemistry Analyzer Presented at IBMS 2015

By LabMedica International staff writers
Posted on 11 Oct 2015
Print article
The new Altair 240 bench-top clinical chemistry analyzer with LIS bi-directional connectivity
The new Altair 240 bench-top clinical chemistry analyzer with LIS bi-directional connectivity (Photo courtesy of EKF Diagnostics)
A new clinical chemistry analyzer provides an automated bench-top platform with an integrated chemistry system supported by a broad menu of ready-to-use, bar coded reagents.

EKF Diagnostics (Cardiff, UK) announced the UK launch of its “Altair 240” clinical chemistry analyzer at the Institute of Biomedical Science Congress 2015 (IBMS, September 28-30, 2015; Birmingham, UK). Also highlighted was the latest additions to its range of Stanbio liquid-stable, LiquiColor and Liqui-UV reagents, including an assay for Procalcitonin.

Altair 240 fulfills a need for an automated, cost-effective bench-top platform supported by the reliable Stanbio Chemistry liquid reagent menu for routine and special chemistries. Altair 240 also provides the flexibility to configure open-channel applications for many esoteric assays. Built on 54 years of expertise, the system with LIS bi-directional connectivity is easy-to-use, as either a main or back-up analyzer, and is capable of performing up to 480 tests/hour (double-arm functionality yields up to 480 tests/hour).

Also presented at IBMS 2015 was the Stanbio Chemistry - Procalcitonin (PCT) LiquiColor Assay, a new rapid test enabling the quantitative determination of PCT in serum samples, EDTA, or lithium heparin plasma samples by latex-enhanced immunoturbidimetric methodology. PCT is a marker for bacterial infection and sepsis and has been recognized as an important adjunct marker in the diagnosis of sepsis. The test provides a precise result that correlates well with established methodology, within 10 minutes and requires only 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyzer with open-channel capability. Reagent kit, calibrator, and control sets are available separately.

Other products showcased at EKF’s IBMS booth included: B-Hydroxybutyrate (B-HB) LiquiColor Assay for ketosis testing; Glycated Serum Protein (GSP) LiquiColor Assay – a 2-3 week indicator of average blood glucose; Quo-Lab and Quo-Test devices for HbA1c measurement; and Hemo Control hemoglobin analyzer.

Related Links:

EKF Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.